Back to Search
MIA GUZMAN, M.D.
M.D.
Family Medicine Physician
NPI: 1295141570IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
T3292(TX)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).
PMID 19505822·Bioorg Med Chem Lett·2009
7-preclinical
Gastric Burkitt lymphoma: A rare cause of upper gastrointestinal bleeding in a child with HIV/AIDS.
PMID 19179888·J Pediatr Gastroenterol Nutr·2009
5-case
Phage-displayed antibody fragments recognizing dengue 3 and dengue 4 viruses as tools for viral serotyping in sera from infected individuals.
PMID 19504165·Arch Virol·2009
8-other
Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia.
PMID 18511080·J Surg Res·2009
7-preclinical
Lessons learned from the study of JunB: new insights for normal and leukemia stem cell biology.
PMID 19345324·Cancer Cell·2009
7-preclinical
Neuropathology of 3-hydroxyisobutyric aciduria, an autopsy case report.
PMID 19650361·Can J Neurol Sci·2009
5-case
Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity.
PMID 19060928·Oncogene·2009
7-preclinical
Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.
PMID 19621458·Pediatr Blood Cancer·2009
5-case
Immunoglobulin G antibody response in children and adults with acute dengue 3 infection.
PMID 19442837·J Virol Methods·2009
7-preclinical
Monoclonal antibodies against IREM-1: potential for targeted therapy of AML.
PMID 19440216·Leukemia·2009
7-preclinical
Vascular endothelial growth factor improves myocardial functional recovery following ischemia/reperfusion injury.
PMID 18619619·J Surg Res·2008
7-preclinical
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
PMID 18829560·Cancer Res·2008
7-preclinical
Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines.
PMID 18941461·Br J Cancer·2008
4-observational
Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007.
PMID 18420239·Trans R Soc Trop Med Hyg·2008
6-review
JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.
PMID 18454173·Oncogene·2008
7-preclinical
The productivity measurement and enhancement system: a meta-analysis.
PMID 18457486·J Appl Psychol·2008
1-meta
Genetic background in apolipoprotein A-I and cystathionine beta-synthase deficiency.
PMID 18508577·Front Biosci·2008
7-preclinical
Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.
PMID 19010894·Cancer Res·2008
7-preclinical
Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study.
PMID 18346173·Clin Exp Pharmacol Physiol·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2801 FRANCISCAN DR
BRYAN, TX 77802 - Phone
- (531) 228-0135
Quick Facts
- NPI
- 1295141570
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile